Sanofi (LON:0A2V)
London · Delayed Price · Currency is GBP · Price in USD 46.71
+0.49 (1.05%)
At close: Jan 30, 2026
Sanofi Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 |
Depreciation & Amortization | 3,210 | 3,110 | 3,247 | 3,053 | 3,001 |
Other Amortization | - | 106 | 120 | 97 | 119 |
Loss (Gain) From Sale of Assets | - | -298 | -103 | -470 | -357 |
Asset Writedown & Restructuring Costs | - | 370 | 1,062 | -42 | 231 |
Loss (Gain) on Equity Investments | - | 82 | 293 | -45 | -15 |
Stock-Based Compensation | - | 278 | 260 | 234 | 244 |
Other Operating Activities | -462 | -44 | -1,457 | -879 | -389 |
Change in Accounts Receivable | - | -28 | -472 | -500 | 185 |
Change in Inventory | - | -477 | -866 | -918 | -357 |
Change in Accounts Payable | - | 789 | 258 | 340 | 451 |
Change in Other Net Operating Assets | - | -899 | 1,493 | 284 | 1,130 |
Operating Cash Flow | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 |
Operating Cash Flow Growth | 18.38% | -11.47% | -2.55% | 0.04% | 41.84% |
Capital Expenditures | -1,858 | -1,733 | -1,619 | -1,529 | -1,478 |
Sale of Property, Plant & Equipment | 744 | 1,461 | 807 | 1,340 | 676 |
Cash Acquisitions | - | -1,901 | -2,535 | -987 | -5,594 |
Sale (Purchase) of Intangibles | -1,761 | -1,462 | -1,287 | -574 | -565 |
Investment in Securities | - | -623 | -92 | -353 | -269 |
Other Investing Activities | 428 | -149 | -1,474 | 28 | -68 |
Investing Cash Flow | -2,447 | -4,407 | -6,200 | -2,075 | -7,298 |
Short-Term Debt Issued | - | 59 | 751 | 216 | - |
Long-Term Debt Issued | - | - | 48 | 1,549 | - |
Total Debt Issued | - | 59 | 799 | 1,765 | - |
Short-Term Debt Repaid | - | - | - | - | -414 |
Long-Term Debt Repaid | - | -953 | -3,936 | -2,998 | -2,390 |
Total Debt Repaid | - | -953 | -3,936 | -2,998 | -2,804 |
Net Debt Issued (Repaid) | - | -894 | -3,137 | -1,233 | -2,804 |
Issuance of Common Stock | - | 187 | 195 | 188 | 186 |
Repurchase of Common Stock | - | -302 | -593 | -497 | -382 |
Common Dividends Paid | - | -4,704 | -4,454 | -4,168 | -4,008 |
Other Financing Activities | -8,207 | -50 | -63 | -111 | -48 |
Financing Cash Flow | -8,207 | -5,763 | -8,052 | -5,821 | -7,056 |
Foreign Exchange Rate Adjustments | -47 | -13 | -32 | 8 | 15 |
Miscellaneous Cash Flow Adjustments | 167 | -167 | - | - | - |
Net Cash Flow | 216 | -1,269 | -4,026 | 2,638 | -3,817 |
Free Cash Flow | 8,892 | 7,348 | 8,639 | 8,997 | 9,044 |
Free Cash Flow Growth | 21.01% | -14.94% | -3.98% | -0.52% | 46.72% |
Free Cash Flow Margin | 19.03% | 16.59% | 21.02% | 22.32% | 23.09% |
Free Cash Flow Per Share | 7.29 | 5.85 | 6.88 | 7.16 | 7.19 |
Cash Interest Paid | - | 587 | 559 | 380 | 334 |
Cash Income Tax Paid | - | 3,291 | 2,623 | 2,452 | 1,280 |
Levered Free Cash Flow | 15,941 | -4,944 | 7,173 | 8,514 | 7,336 |
Unlevered Free Cash Flow | 16,293 | -4,543 | 7,541 | 8,765 | 7,562 |
Change in Working Capital | - | -615 | 413 | -794 | 1,409 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.